Pharmaceutical manufacturers, both branded and generic, are coming
to realise leveraging patents on their intellectual property plays an
integral role in their business strategy. By fully understanding how to
capitalise on the opportunities presented in the current market, your
company will be better placed to turn threats into innovative and
profitable business solutions.
Who should attend?
Generic manufacturers
Brand pharma manufacturers
IP and patent attorneys and strategists
Government bodies and regulators
Lifecycle and marketing executives
Legal firms
Agenda
9.00 Registration and Coffee
9.30 Masterclass commences
Understanding patents and the protection they afford
Patent extensions and springboarding provisions
Evergreening and the knock-on effects
Other IP-related protection
Regulatory considerations in circumventing patents
Patent validity, infringement and interference actions
1.00 Close of Masterclass
Course times and documentation
Registration starts at 9.00am. The Masterclass will commence
at 9.30am and finish at 1.00pm. Refreshments will be served at
appropriate times. Participants will receive all Masterclass
materials.
About your Masterclass leader
Leighton Howard Managing Director XIP and GenericsWeb
Leighton Howard is the founder and Managing Director of XIP
and GenericsWeb, a provider of Generic Pharmaceutical
Intelligence to government institutions, legal practices and
industry firms in over 30 countries. He also acts as a consultant
in the development of generic pharmaceuticals, specialising in
patent strategy. Leighton has extensive experience in patent
searching and information management, starting off as a
professional patent searcher with RWS. He then moved into
generic pharma IP, taking a position at IVAX Pharmaceuticals
(UK) where he was responsible for meeting the patent
information needs for the global generic development portfolio.
